Grace Therapeutics, Inc. (ACST)
1.93
+0.02
(+0.78%)
USD |
NASDAQ |
Oct 23, 16:00
Grace Therapeutics Price to Book Value : 0.6515 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.6515 |
| October 22, 2026 | 0.6464 |
| October 21, 2026 | 0.665 |
| October 20, 2026 | 0.6684 |
| October 19, 2026 | 0.6346 |
| October 16, 2026 | 0.638 |
| October 15, 2026 | 0.6582 |
| October 14, 2026 | 0.638 |
| October 13, 2026 | 0.6717 |
| October 12, 2026 | 0.6819 |
| October 09, 2026 | 0.7021 |
| October 08, 2026 | 0.6886 |
| October 07, 2026 | 0.7089 |
| October 06, 2026 | 0.6971 |
| October 05, 2026 | 0.6954 |
| October 02, 2026 | 0.6987 |
| October 01, 2026 | 0.6886 |
| September 30, 2026 | 0.7257 |
| September 29, 2026 | 0.7122 |
| September 28, 2026 | 0.7156 |
| September 25, 2026 | 0.7156 |
| September 24, 2026 | 0.7291 |
| September 23, 2026 | 0.7156 |
| September 22, 2026 | 0.7224 |
| September 21, 2026 | 0.7089 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.7122 |
| September 17, 2026 | 0.719 |
| September 16, 2026 | 0.7224 |
| September 15, 2026 | 0.7528 |
| September 14, 2026 | 0.773 |
| September 11, 2026 | 0.7494 |
| September 10, 2026 | 0.7629 |
| September 09, 2026 | 0.7224 |
| September 08, 2026 | 0.7156 |
| September 04, 2026 | 0.7089 |
| September 03, 2026 | 0.7224 |
| September 02, 2026 | 0.7224 |
| September 01, 2026 | 0.7089 |
| August 31, 2026 | 0.719 |
| August 28, 2026 | 0.7156 |
| August 27, 2026 | 0.7291 |
| August 26, 2026 | 0.7257 |
| August 25, 2026 | 0.7426 |
| August 24, 2026 | 0.7359 |
| August 21, 2026 | 0.7426 |
| August 20, 2026 | 0.7224 |
| August 19, 2026 | 0.7426 |
| August 18, 2026 | 0.719 |
| August 17, 2026 | 0.7291 |
| August 14, 2026 | 0.7291 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Abeona Therapeutics, Inc. | 1.966 |
| America Great Health | -- |
| Acumen Pharmaceuticals, Inc. | 2.500 |
| Aardvark Therapeutics, Inc. | 0.4067 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0374 |
| Price | 1.93 |
| Earnings Yield | -61.32% |
| Market Cap | 31.41M |
| PEGY Ratio | -0.0374 |